• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa.

作者信息

Baerveldt Ewout M, Kappen Jasper H, Thio H Bing, van Laar Jan Am, van Hagen P Martin, Prens Errol P

出版信息

Ann Rheum Dis. 2013 Apr;72(4):626-7. doi: 10.1136/annrheumdis-2012-202392. Epub 2012 Nov 12.

DOI:10.1136/annrheumdis-2012-202392
PMID:23148307
Abstract
摘要

相似文献

1
Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa.优特克单抗成功长期控制一名患有白塞病、银屑病和化脓性汗腺炎患者的三种疾病。
Ann Rheum Dis. 2013 Apr;72(4):626-7. doi: 10.1136/annrheumdis-2012-202392. Epub 2012 Nov 12.
2
Management of recalcitrant hidradenitis suppurativa with ustekinumab.用优特克单抗治疗顽固性化脓性汗腺炎
Acta Derm Venereol. 2012 May;92(3):320-1. doi: 10.2340/00015555-1229.
3
Behçet's disease associated with hidradenitis suppurativa.
J Eur Acad Dermatol Venereol. 2007 Mar;21(3):428-9. doi: 10.1111/j.1468-3083.2006.01922.x.
4
Concomitant psoriasis and hidradenitis suppurativa responsive to adalimumab therapy: A case series.阿达木单抗治疗伴发银屑病和化脓性汗腺炎有效：一组病例报告。
Indian J Dermatol Venereol Leprol. 2021 Mar-Apr;87(2):223-226. doi: 10.4103/ijdvl.IJDVL_455_18.
5
Neutrophilic dermatosis and hidradenitis suppurativa in patients with Behçet's disease: A neutrophilic disease in the spectrum of autoinflammatory syndromes.
Semin Arthritis Rheum. 2023 Aug;61:152224. doi: 10.1016/j.semarthrit.2023.152224. Epub 2023 May 13.
6
Case report: Treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches.病例报告：采用不同治疗方法治疗化脓性汗腺炎和银屑病共存。
F1000Res. 2019 Nov 26;8:2002. doi: 10.12688/f1000research.21216.2. eCollection 2019.
7
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on 'Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab'.阿达木单抗生物类似药诱发的反常性化脓性汗腺炎在一名银屑病患者中成功用古塞库单抗治疗。对“因抗白细胞介素-1药物治疗甲羟戊酸激酶缺乏症导致的反常性化脓性汗腺炎通过加用乌司奴单抗成功治疗”的评论
Clin Exp Dermatol. 2023 Jun 5;48(6):701-703. doi: 10.1093/ced/llad082.
8
Reply to 'Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab"'.对“阿达木单抗生物类似药诱发的反常性化脓性汗腺炎在一名银屑病患者中成功用古塞库单抗治疗。评‘因抗白细胞介素-1药物治疗甲羟戊酸激酶缺乏症导致的反常性化脓性汗腺炎通过加用乌司奴单抗成功治疗’”的回复
Clin Exp Dermatol. 2023 Jul 21;48(8):940-941. doi: 10.1093/ced/llad160.
9
Psoriasis Onset during Anti-TNF Treatment for Hidradenitis Suppurativa: Successful Remission of Both Conditions with Secukinumab.化脓性汗腺炎抗TNF治疗期间银屑病发病：司库奇尤单抗成功缓解两种病症。
Skinmed. 2023 Mar 29;21(1):57-58. eCollection 2023.
10
Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease.古塞库单抗治疗化脓性汗腺炎、银屑病和克罗恩病。
J Dermatolog Treat. 2021 Mar;32(2):261-263. doi: 10.1080/09546634.2019.1654067. Epub 2019 Aug 25.

引用本文的文献

1
Decoding Behcet's Uveitis: an In-depth review of pathogenesis and therapeutic advances.贝赫切特葡萄膜炎的解码：发病机制和治疗进展的深入综述。
J Neuroinflammation. 2024 May 22;21(1):133. doi: 10.1186/s12974-024-03123-6.
2
Advances in pathogenesis and treatment of ocular involvement in Behcet's disease.贝赫切特病眼部受累的发病机制和治疗进展。
Front Immunol. 2023 Sep 29;14:1206959. doi: 10.3389/fimmu.2023.1206959. eCollection 2023.
3
Intestinal Behcet's Disease: A Review of the Immune Mechanism and Present and Potential Biological Agents.
肠白塞病：免疫机制及现有和潜在生物制剂的综述。
Int J Mol Sci. 2023 May 3;24(9):8176. doi: 10.3390/ijms24098176.
4
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience.阿达木单抗、优特克单抗和司库奇尤单抗治疗化脓性汗腺炎：真实世界经验综述
Clin Cosmet Investig Dermatol. 2023 Jan 19;16:135-148. doi: 10.2147/CCID.S391356. eCollection 2023.
5
New insights on multigenic autoinflammatory diseases.多基因自身炎症性疾病的新见解
Ther Adv Musculoskelet Dis. 2022 Sep 3;14:1759720X221117880. doi: 10.1177/1759720X221117880. eCollection 2022.
6
Neutrophilic Dermatosis and Management Strategies for the Inpatient Dermatologist.嗜中性皮病与住院皮肤科医生的管理策略
Curr Dermatol Rep. 2022;11(3):146-157. doi: 10.1007/s13671-022-00364-7. Epub 2022 Jul 16.
7
Use of non-TNF biologics for the treatment of neuro-Behçet's disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab.非肿瘤坏死因子生物制剂用于治疗神经白塞病：文献综述及2例用托珠单抗治疗的单克隆抗肿瘤坏死因子难治性病例
Eur J Rheumatol. 2021 Oct;8(4):223-227. doi: 10.5152/eurjrheum.2021.20160.
8
Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.乌司奴单抗在非适应证皮肤科疾病中的其他用途：系统评价。
Arch Dermatol Res. 2022 Aug;314(6):503-514. doi: 10.1007/s00403-021-02262-7. Epub 2021 Jun 22.
9
Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach.白塞病的治疗：一种多学科算法治疗方法。
Front Med (Lausanne). 2021 Apr 28;8:624795. doi: 10.3389/fmed.2021.624795. eCollection 2021.
10
Pathogenesis of Non-Infectious Uveitis Elucidated by Recent Genetic Findings.最近的遗传发现阐明了非感染性葡萄膜炎的发病机制。
Front Immunol. 2021 Apr 12;12:640473. doi: 10.3389/fimmu.2021.640473. eCollection 2021.